Literature DB >> 22297252

Identification of a novel mutation in the HAMP gene that causes non-detectable hepcidin molecules in a Japanese male patient with juvenile hemochromatosis.

Ai Hattori1, Naohisa Tomosugi, Yasuaki Tatsumi, Ayami Suzuki, Kazuhiko Hayashi, Yoshiaki Katano, Yasutaka Inagaki, Tetsuya Ishikawa, Hisao Hayashi, Hidemi Goto, Shinya Wakusawa.   

Abstract

Hepcidin is an iron-regulatory hepatic peptide hormone encoded by the HAMP gene that downregulates iron export from enterocytes and macrophages into the blood plasma. In this study, we identified a novel mutation in the HAMP gene of a 58-year-old Japanese male patient with hemochromatosis. By direct sequencing of the five hereditary hemochromatosis-related genes, HFE, HAMP, HJV, TFR2, and SLC40A1, the previously unreported p.R75X mutation was identified, and the patient was found to be homozygous for the mutation. No other potentially pathogenic mutations were detected. In an LC-MS/MS analysis, hepcidin molecules were not detected in the patient's serum or urine. These results indicate that the p.R75X mutation causes iron overload by impairing the hepcidin system.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297252     DOI: 10.1016/j.bcmd.2012.01.002

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  8 in total

Review 1.  The mechanisms of systemic iron homeostasis and etiology, diagnosis, and treatment of hereditary hemochromatosis.

Authors:  Hiroshi Kawabata
Journal:  Int J Hematol       Date:  2017-11-13       Impact factor: 2.490

2.  Iron overload patients with unknown etiology from national survey in Japan.

Authors:  Katsuya Ikuta; Mayumi Hatayama; Lynda Addo; Yasumichi Toki; Katsunori Sasaki; Yasuaki Tatsumi; Ai Hattori; Ayako Kato; Koichi Kato; Hisao Hayashi; Takahiro Suzuki; Masayoshi Kobune; Miyuki Tsutsui; Akihiko Gotoh; Yasuo Aota; Motoo Matsuura; Yuzuru Hamada; Takahiro Tokuda; Norio Komatsu; Yutaka Kohgo
Journal:  Int J Hematol       Date:  2016-11-15       Impact factor: 2.490

Review 3.  Iron homeostasis in the liver.

Authors:  Erik R Anderson; Yatrik M Shah
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

Review 4.  Ethnic Differences in Iron Status.

Authors:  Wanhui Kang; Alexa Barad; Andrew G Clark; Yiqin Wang; Xu Lin; Zhenglong Gu; Kimberly O O'Brien
Journal:  Adv Nutr       Date:  2021-10-01       Impact factor: 8.701

5.  Iranian hereditary hemochromatosis patients: baseline characteristics, laboratory data and gene mutations.

Authors:  Farhad Zamani; Zohreh Bagheri; Maryam Bayat; Seyed-Mohammad Fereshtehnejad; Ali Basi; Hossein Najmabadi; Hossein Ajdarkosh
Journal:  Med Sci Monit       Date:  2012-10

6.  A low-molecular-weight compound K7174 represses hepcidin: possible therapeutic strategy against anemia of chronic disease.

Authors:  Tohru Fujiwara; Takashi Ikeda; Yuki Nagasaka; Yoko Okitsu; Yuna Katsuoka; Noriko Fukuhara; Yasushi Onishi; Kenichi Ishizawa; Ryo Ichinohasama; Naohisa Tomosugi; Hideo Harigae
Journal:  PLoS One       Date:  2013-09-27       Impact factor: 3.240

Review 7.  Iron metabolism: current facts and future directions.

Authors:  Leida Tandara; Ilza Salamunic
Journal:  Biochem Med (Zagreb)       Date:  2012       Impact factor: 2.313

Review 8.  Atypical juvenile hereditary hemochromatosis onset with positive pancreatic islet autoantibodies diabetes caused by novel mutations in HAMP and overall clinical management.

Authors:  Hui-Xuan Wu; Jun-Ying Liu; De-Wen Yan; Long Li; Xiang-Hua Zhuang; Hai-Yan Li; Zhi-Guang Zhou; Hou-De Zhou
Journal:  Mol Genet Genomic Med       Date:  2020-10-05       Impact factor: 2.183

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.